Israel to buy Novavax COVID vaccine

Gaithersburg, Maryland-based Novavax, expected to formally apply for U.S. Food and Drug Administration emergency use approval for its protein-based COVID-19 vaccine next week, has added Israel to countries buying the vaccine.

Israel’s Ministry of Health announced an agreement to purchase an initial 5 million doses of the vaccine, with the option to buy another 5 million. Novavax will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israel, pending regulatory approval.

“Israel has been at the forefront of the fight against COVID-19 and has demonstrated strong leadership throughout the pandemic,” said Novavax CEO Stanley Erck.



To date, Novavax has received conditional authorization from the European Union and Emergency Use Listing from the World Health Organization.

It has also received authorization for its vaccine in India, and its two-dose vaccine is already being distributed in Indonesia and the Philippines. Novavax has authorizations pending in several other countries, including South Korea and Japan.

Novavax completed submission of the final data package to the FDA Dec. 31, the last prerequisite in the FDA’s emergency use authorization application process. The submission started a one-month procedure of review; pending the outcome of that review, the formal request for a EUA comes next.

Jeff Clabaugh

Jeff Clabaugh has spent 20 years covering the Washington region's economy and financial markets for WTOP as part of a partnership with the Washington Business Journal, and officially joined the WTOP newsroom staff in January 2016.

Like WTOP on Facebook and follow WTOP on Twitter and Instagram to engage in conversation about this article and others.

Get breaking news and daily headlines delivered to your email inbox by signing up here.

© 2022 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up